Pregnancy termination between 12 and 14 weeks gestation: Practices and early complications in comparison with termination between 8 and 12 weeks;Conditions de réalisation et complications précoces des IVG entre 12 et 14 semaines d'aménorrhée comparées aux IVG entre 8 et 12 semaines d'aménorrhée

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 34, Issue 4, 2005, Pages 339-345

  Bacle, F ^a   Boufassa, F ^b   Lambert, J ^b   Lefebvre, P ^c   Soulat, C ^a   Meyer, L ^b  

^a HÔPITAL LOUIS MOURIER   (France)

^b INSERM   (France)

^c CENTRE HOSPITALIER DE ROUBAIX   (France)

Author keywords

First trimester pregnancy; Surgical abortion

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANNULATION; CLINICAL PRACTICE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; MAJOR CLINICAL STUDY; OPERATION DURATION; PAIN; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PREGNANCY TERMINATION; SECOND TRIMESTER PREGNANCY; UTERINE CERVIX DILATATION;

EID: 20944435270     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0368-2315(05)82839-x     Document Type: Article

References (25)

1. Loi n° 75-17 du 17 janvier 1975 relative à l'IVG. Journal Officiel; 18 janvier 1975: 1-6.
2. Lecorre M, Thomson E. Les IVG en 1998. Journal de la DREES 2000; 69: 1-4.
3. Confalone N. Abortion legislation in Europe. Choices 2000; 2: 2-7.
4. L'IVG en France. La Revue Prescrire 2000; 209: 630-2.
5. Loi n° 2001-588 du 4 juillet 2001 relative à l'IVG et à la contraception. Journal Officiel; 7 juillet 2001: 108-23.
6. Prise en charge de l'interruption volontaire de grossesse jusqu'à 14 semaines. ANAES; mars 2001.
7. WHO. Task Force on Prostaglandins for Fertility Regulation N. Vaginal administration of 15-methyl-PGE2 a methyl ester for preoperative cervical dilatation. Contraception 1981; 23: 251-9.
8. Ngai SW, Tang OS, Lao T, Ho PC, Ma HK. Oral misoprostol versus placebo for cervical dilatation before vacuum aspiration in first trimester pregnancy. Hum Reprod 1995; 10: 1220-2.
9. Ngai SW, Yeung KC, Lao T, Ho PC. Oral misoprostol versus mifepristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancy: a double blind prospective randomized study. Br J Obstet Gynaecol 1996; 103: 1120-3.
10. Singh K, Fong YF, Prasad RNV, Dong F. Randomizes trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming. Obstet Gynecol 1998; 92: 795-8.
11. Ngai SW, Chan YM, Tang OS, Ho PC. The use of misoprostol for pre-operative cervical dilatation prior to vacuum aspiration. Hum Reprod 1999; 94: 431-4.
12. Ashok PW, Flett GM, Templeton A. Mifepristone versus vaginally administered misoprostol for cervical priming before first trimester termination of pregnancy: a randomized, controlled study. Am J Obstet Gynecol 2000; 183: 998-1002.
13. Sawaya GF, Grady D, Kerlikowske K, Grimes DA. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol 1996; 87: 884-90.
14. Houang ET. Antibiotics prophylaxis in hysterectomy and induced abortion. A review of the evidence. Drugs 1991; 41: 19-37.
15. Penney GC, Thomson M, Norman J, Mckenzie H, Vale L, Smith R et al. A randomized comparison of strategies for reducing infective complications of induced abortion. Br J Obstet Gynaecol 1998; 105: 599-604.
16. Mazzaro J, Connie L, Hillis S, Fine D, Deslile S, Handsfield H. Performance and cost-effectiveness of selective sreening criteria for Chlamydiae trachomatis infection in women. Implications for a national chlamydia control strategy. Sex Transm Dis 1997; 24: 131-41.
17. Quesnot S, Soulat C, Weber P, Gros I, Boussougant Y, Meyer L. Chlamydia trachomatis: prévalence et facteurs de risque du portage cervical dans une consultation d'IVG et de planification familiale. Bull Epid Hebdom 1989; 33: 133-5.
18. WHO. Medical methods for termination of pregnancy. WHO technical report series, Geneva, 1997, 871: 110 pages.
19. Kaunitz AM, Rovira EZ, Grimes DA, Schulz KF. Abortions that fail. Obstet Gynecol 1985; 66: 533-7.
20. Hakim-Elahi E, Tovell HMM, Burnhill MS. Complications of first-trimester-abortion: a report of 170 000 cases. Obstet Gynecol 1990; 76: 129-35.
21. Thonneau P, Fougeyrollas B, Ducot B, Boubilley D, Dif J, Lalande M et al. Complications of abortion performed under local anesthesia. Eur J Obstet Gynecol Reprod Biol 1998; 81: 59-63.
22. Keder LM. Best practices in surgical abortion. Am J Obstet Gynecol 2003; 189: 119-24.
23. Belanger E, Melzack R, Louzon P. Pain of first-trimester abortion: a study of psychosocial and medical predictors. Pain 1989; 36: 339-50.
24. Edelman A, Nichols MD, Leclair C, Astley S, Shy K, Jensen JT. Intrauterine lidocaine infusion for pain management in first trimester abortions. Obstet Gynecol 2004; 103: 1267-72.
25. Kan AS, Ng EH, Ho PC. The role and comparison of two techniques of paracervical block for pain relief during suction evacuation for first-trimester pregnancy termination. Contraception 2004; 70: 159-163.